The Closer Trial: A Safety and Efficacy Study of the Rex Medical Vascular Sealing System

NACompletedINTERVENTIONAL
Enrollment

220

Participants

Timeline

Start Date

May 31, 2014

Primary Completion Date

February 28, 2015

Study Completion Date

February 28, 2015

Conditions
Surgical Wound
Interventions
DEVICE

Closer VSS

At the end of a percutaneous endovascular procedure, the femoral arterial access site is closed with the Closer device to achieve arterial hemostasis.

Trial Locations (12)

10065

New York Presbyterian Hospital, New York

17043

Pinnacle Health, Wormleysburg

17822

Geisinger Health Center, Danville

18711

Geisinger Health Center, Wilkes-Barre

20010

Washington Hospital Center, Washington D.C.

44035

North Ohio Research, Elyria

70503

Lafayette General Medical Center/Cardiovascular Institute of the South, Lafayette

74104

Oklahoma Heart Institute, Tulsa

78756

Heart Hospital of Austin, Austin

80113

Colorado Neurological Institute, Englewood

95817

UC Davis Medical Center, Sacramento

97239-3098

Oregon Health & Science University, Portland

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Rex Medical

INDUSTRY